Evidence map›Paper›PMID 28098217›Full record

ArticleScientific reports2017

Disrupting Hepatocyte Cyp51 from Cholesterol Synthesis Leads to Progressive Liver Injury in the Developing Mouse and Decreases RORC Signalling.

Žiga Urlep, Gregor Lorbek, Martina Perše, Jera Jeruc, Peter Juvan, Madlen Matz-Soja, Rolf Gebhardt, Ingemar Björkhem, Jason A Hall, Richard Bonneau and 2 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 35 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Observational
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Frontiers in physiology · 2018
    Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 4 countries.

Žiga UrlepCentre for Functional Genomics and Bio-Chips, Institute of Biochemistry, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia.
Gregor LorbekCentre for Functional Genomics and Bio-Chips, Institute of Biochemistry, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia.
Martina PeršeMedical Experimental Centre, Institute of Pathology, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia.
Jera JerucInstitute of Pathology, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia.
Peter JuvanCentre for Functional Genomics and Bio-Chips, Institute of Biochemistry, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia.
Madlen Matz-SojaInstitute of Biochemistry, Faculty of Medicine, University of Leipzig, Leipzig, Germany.
Rolf GebhardtInstitute of Biochemistry, Faculty of Medicine, University of Leipzig, Leipzig, Germany.
Ingemar BjörkhemDepartment of Laboratory Medicine, Division of Clinical Chemistry, Karolinska Institute, Karolinska University Hospital, Huddinge, Sweden.
Jason A HallThe Kimmel Center for Biology and Medicine of the Skirball Institute, New York University School of Medicine, New York, New York 10016, USA.
Richard BonneauNew York University &Simons Foundation for Data Analysis, New York, NY 10010, USA.
Dan R LittmanThe Kimmel Center for Biology and Medicine of the Skirball Institute, New York University School of Medicine, New York, New York 10016, USA.
Damjana RozmanCentre for Functional Genomics and Bio-Chips, Institute of Biochemistry, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia.
University of Ljubljana · SILeipzig University · DENew York University · USKarolinska Institutet · SESimons Foundation · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Development of mice with hepatocyte knockout of lanosterol 14α-demethylase (H

Indexed as

Signal TransductionAnimalsCholesterolCytochrome P450 Family 51Disease Models, AnimalDisease ProgressionFemaleFibrosisGene Expression ProfilingGene Expression RegulationHepatocytesLiver DiseasesMaleMiceMice, KnockoutNuclear Receptor Subfamily 1, Group F, Member 3CholesterolCytochrome P450 Family 51Nuclear Receptor Subfamily 1, Group F, Member 3Rorc protein, mouseSterols

Identifiers

PMID28098217
PMCPMC5241696
OpenAlexW2578808057

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.